BioCryst starts phase I pharmacokinetic study of Fodosine
Fodosine (forodesine hydrochloride) is a transition state purine nucleoside phosphorylase (PNP) inhibitor, which functions by blocking the DNA synthesis machinery of the body’s T-cells. The small molecule drug
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.